PARBOLD THERAPEUTICS LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Parbold Therapeutics Limited. The company was founded 8 years ago and was given the registration number 10564195. The firm's registered office is in WARRINGTON. You can find them at Lowton Business Park, Lowton St. Mary's, Warrington, Cheshire. This company's SIC code is 21200 - Manufacture of pharmaceutical preparations.

Company Information

Name	:	PARBOLD THERAPEUTICS LIMITED
Company Number	:	10564195
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active
Incorporation Date	:	16 January 2017
End of financial year	:	31 January 2023
Jurisdiction	:	England - Wales
Industry Codes	:	21200 - Manufacture of pharmaceutical preparations

Office Address & Contact

Registered Address	:	Lowton Business Park, Lowton St. Mary's, Warrington, Cheshire, England, WA3 2AP
Country Origin	:	ENGLAND
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

People with Significant Control

Mr Paul Boulton
Notified on	:	16 January 2017
Status	:	Active
Date of birth	:	July 1959
Nationality	:	British
Country of residence	:	England
Address	:	365, Atherton Road, Wigan, England, WN2 3XD
Nature of control	:	Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors

Mr Nicholas Ralphe Rogerson
Notified on	:	16 January 2017
Status	:	Active
Date of birth	:	February 1955
Nationality	:	British
Country of residence	:	England
Address	:	365, Atherton Road, Wigan, England, WN2 3XD
Nature of control	:	Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (1 year ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (0 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (1 year ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (2 months remaining)